| Product NDC: | 59011-451 |
| Proprietary Name: | DILAUDID |
| Non Proprietary Name: | HYDROMORPHONE HYDROCHLORIDE |
| Active Ingredient(s): | 5 mg/5mL & nbsp; HYDROMORPHONE HYDROCHLORIDE |
| Administration Route(s): | ORAL |
| Dosage Form(s): | LIQUID |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 59011-451 |
| Labeler Name: | Purdue Pharma LP |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA019891 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19260112 |
| Package NDC: | 59011-451-01 |
| Package Description: | 473 mL in 1 BOTTLE (59011-451-01) |
| NDC Code | 59011-451-01 |
| Proprietary Name | DILAUDID |
| Package Description | 473 mL in 1 BOTTLE (59011-451-01) |
| Product NDC | 59011-451 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | HYDROMORPHONE HYDROCHLORIDE |
| Dosage Form Name | LIQUID |
| Route Name | ORAL |
| Start Marketing Date | 19260112 |
| Marketing Category Name | NDA |
| Labeler Name | Purdue Pharma LP |
| Substance Name | HYDROMORPHONE HYDROCHLORIDE |
| Strength Number | 5 |
| Strength Unit | mg/5mL |
| Pharmaceutical Classes | Full Opioid Agonists [MoA],Opioid Agonist [EPC] |